<DOC>
	<DOCNO>NCT00711100</DOCNO>
	<brief_summary>Recently , tobacco company develop new oral tobacco product purportedly less harmful conventional tobacco product . These product test independent research health effect consumer palatability . In addition , know product use addition cigarette smoke substitute cigarette . These two study examine four oral tobacco product answer question . The goal first study examine : 1 ) brand oral tobacco product prefer cigarette smoker pattern amount product use use switch tool ; 2 ) characteristic associated product choice ; 3 ) nicotine exposure product ; 4 ) withdrawal symptom tobacco product potential continue use . Specifically , primary aim hypothesis : 1 ) product choose smoker base taste sensory aspect product product high nicotine content likely chosen preferred product ; 2 ) subject experience difficulty use product cessation , small minority engage dual product use . For secondary aim , hypothesize : 1 ) compare subject ' brand cigarette , biomarkers exposure oral tobacco product significantly low ; 2 ) withdrawal symptom oral product likely occur , likely mild compare cigarette withdrawal .</brief_summary>
	<brief_title>Evaluation Oral Tobacco Harm Reduction Method Smokers</brief_title>
	<detailed_description>This study accomplish allow subject sample product choose one oral tobacco product use instead cigarette two week period . After two week , discontinue tobacco use withdrawal symptom abstinence rate observe . Subjects attend orientation visit study explain detail . Interested subject sign consent form schedule return baseline measure . Subjects review medical history verify generally good health contraindication study product . Eligible subject collect one week baseline measure smoke normal rate : measure include daily diary smoking , questionnaires urine sample . At second baseline visit , receive sample oral tobacco product . The tobacco product test five novel oral product recently introduce market : 1 ) Camel Snus ( high nicotine ) ; 2 ) General Snus ( high nicotine ) ; 3 ) Marlboro Snus ( low nicotine ) ; two compress tobacco tablet , 4 ) Ariva ( low nicotine ) , 5 ) Stonewall ( high nicotine ) . All tobacco product purport reduced level tobacco-specific nitrosamines . During sample week , subject give 10 pouches/tablets product within-subject design instruct use least three daily product morning sample day resume smoke afternoon follow day . They sample next product similar manner . The order product randomize . All subject sample five product . This design allow short , adequate trial product determine preference . After sample week , subject choose product want use quit smoke . They supply product next two week . During two week product use smoking cessation , subject come weekly clinic visit follow-up visit 1 week phone call 4 week end treatment . At baseline , 2 week post cigarette cessation , subject bring urine sample first morning void blood draw . At visit , subject vital sign obtain ( blood pressure , heart rate , weight carbon monoxide level ) , complete several subjective form regard tobacco use , withdrawal symptom , mood . Subjects receive brief behavioral counseling smoking cessation visit . In addition , sample week end two week study product use , subject submit three use chew send CDC analyze tobacco constituent .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<criteria>Cigarette smoker smoke 10 cigarette per day Generally good health Unstable medical psychiatric condition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Smoking cessation</keyword>
	<keyword>Oral tobacco product</keyword>
</DOC>